HomeCARM • NASDAQ
add
Carisma Therapeutics Inc
Previous close
$0.47
Day range
$0.43 - $0.47
Year range
$0.38 - $2.94
Market cap
19.84M USD
Avg Volume
361.90K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 3.38M | -11.55% |
Operating expense | 5.20M | -21.40% |
Net income | -12.70M | 40.65% |
Net profit margin | -375.24 | 32.90% |
Earnings per share | -0.31 | 41.51% |
EBITDA | -12.41M | 42.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.13M | -70.12% |
Total assets | 42.06M | -60.61% |
Total liabilities | 53.18M | -12.07% |
Total equity | -11.13M | — |
Shares outstanding | 41.75M | — |
Price to book | -1.76 | — |
Return on assets | -64.81% | — |
Return on capital | 1,781.03% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -12.70M | 40.65% |
Cash from operations | -13.02M | 38.00% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | -461.00K | 77.32% |
Net change in cash | -13.48M | -298.86% |
Free cash flow | -8.62M | 36.76% |
About
Founded
2008
Headquarters
Website
Employees
107
